Transplacental distribution of salbutamol enantiomers at Caesarian section

被引:7
作者
Boulton, DW
Fawcett, JP
Fiddes, TM
机构
[1] Univ Otago, Sch Pharm, Dunedin, New Zealand
[2] Univ Otago, Sch Med, Dept Obstet & Gynaecol, Dunedin, New Zealand
关键词
Caesarian section; enantiomers; salbutamol; tocolysis; transplacental distribution;
D O I
10.1046/j.1365-2125.1997.t01-1-00617.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To investigate the transplacental distribution of salbutamol enantiomers after administration of racemate to women prior to Caesarian section. Methods Five women about to undergo elective Caesarian section were administered a single 0.25 mg bolus intravenous dose of (R,S)-salbutamol. The time from drug administration to delivery was different for each woman (27-105 min). Maternal and foetal umbilical cord venous blood samples were collected immediately after delivery and the plasma fraction analysed for salbutamol enantiomer concentrations by enantioselective high pressure liquid chromatography. Results The concentrations (mean +/- s.d.) of the active (R) enantiomer of salbutamol in cord and maternal plasma were 0.46 +/- 0.35 and 0.89 +/- 0.50 ng ml(-1), respectively, and the difference was statistically significant (95% confidence interval (CI) of the difference: 0.12-0.74 ng ml(-1)). The corresponding concentrations of the (S) enatiomer of 0.92 +/- 0.45 and 1.11 +/- 0.67 ng ml(-1), respectively, were not significantly different (95% CI of the difference -0.08-0.48 ng ml(-1)). The ratio of (R) : (S) in cord plasma was significantly less than that in maternal plasma (P=0.016). Conclusions Transplacental distribution of salbutamol enantiomers at Caesarian section after prior administration of racemate to mothers leads to concentrations in cord plasma that are significantly less for the active (R) enantiomer and not significantly different for the (S) enantiomer than in maternal plasma presumably due to enantioselective placental-foetal metabolism.
引用
收藏
页码:587 / 590
页数:4
相关论文
共 21 条
[1]  
BERGMAN B, 1984, EUR J RESPIR DIS, V65, P81
[2]   PHARMACOKINETIC EVALUATION IN MAN OF TERBUTALINE GIVEN AS SEPARATE ENANTIOMERS AND AS THE RACEMATE [J].
BORGSTROM, L ;
NYBERG, L ;
JONSSON, S ;
LINDBERG, C ;
PAULSON, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 27 (01) :49-56
[3]   RELATIVE ABSORPTION OF THE 2 ENANTIOMERS OF TERBUTALINE AFTER DUODENAL ADMINISTRATION [J].
BORGSTROM, L ;
KENNEDY, BM ;
NILSSON, B ;
ANGELIN, B .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 38 (06) :621-623
[4]   Enantioselective disposition of albuterol in humans [J].
Boulton, DW ;
Fawcett, JP .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 1996, 14 (01) :115-138
[5]   DETERMINATION OF SALBUTAMOL ENANTIOMERS IN HUMAN PLASMA AND URINE BY CHIRAL HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
BOULTON, DW ;
FAWCETT, JP .
JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS, 1995, 672 (01) :103-109
[6]   Enantioselective disposition of salbutamol in man following oral and intravenous administration [J].
Boulton, DW ;
Fawcett, JP .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 41 (01) :35-40
[7]   Pharmacokinetics and pharmacodynamics of single oral doses of albuterol and its enantiomers in humans [J].
Boulton, DW ;
Fawcett, JP .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (02) :138-144
[8]   SOME OBSERVATIONS ON BETA-ADRENOCEPTOR AGONIST PROPERTIES OF ISOMERS OF SALBUTAMOL [J].
BRITTAIN, RT ;
FARMER, JB ;
MARSHALL, RJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1973, 48 (01) :144-147
[9]   TREATMENT OF PRETERM LABOR - A REVIEW OF THE THERAPEUTIC OPTIONS [J].
CARITIS, SN .
DRUGS, 1983, 26 (03) :243-261
[10]  
DELLENBACH P, 1977, PHARM PERINATALE, V10, P55